HOME › DRUGS › HALOBETASOL PROPIONATE
ACTIVE SUBSTANCE / INN

HALOBETASOL PROPIONATE

Brand name(s): BRYHALI, DUOBRII, HALOBETASOL PROPIONATE AND TAZAROTENE, ULTRAVATE, LEXETTE, HALOBETASOL PROPIONATE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA077721
ANDA214285
ACTIVE SUBSTANCE
Halobetasol Propionate
REGULATORS
FDA
SPONSORS / MAH
PADAGIS ISRAEL, SUN PHARM INDS INC, BAUSCH
TOTAL APPLICATIONS
9
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
HALOBETASOL PROPIONATEANDA077721COSETTEDiscontinued
HALOBETASOL PROPIONATE AND TAZAROTENEANDA217190SUN PHARMA CANADAPrescription
HALOBETASOL PROPIONATEANDA076872PADAGIS ISRAELPrescription
DUOBRIINDA209354BAUSCHPrescription
BRYHALINDA209355BAUSCHPrescription
LEXETTENDA210566MAYNE PHARMADiscontinued
HALOBETASOL PROPIONATEANDA214285PERRIGO ISRAELNone (Tentative Approval)
ULTRAVATENDA019967SUN PHARM INDS INCDiscontinued
ULTRAVATENDA208183LACER PHARMAPrescription

FULL INTELLIGENCE ON HALOBETASOL PROPIONATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →